cancer

Alpine and Merck Study Checkpoint, Anti-PD-1 Cancer Combo in Collab Study
BioSpace
Wed, 06/30/21 - 09:58 pm
Merck
Alpine Immune Sciences
cancer
ALPN-202
Keytruda
How a New Class of Cancer Drug Could Stop Future Coronaviruses
BioSpace
Sat, 06/26/21 - 11:59 pm
AML
cancer
coronaviruses
FDA encourages including incurable cancer patients in trials, regardless of prior therapies
Endpoints
Thu, 06/24/21 - 12:33 pm
FDA
cancer
oncology
clinical trials
Roche's Genentech launches new alliance aimed at achieving greater diversity in cancer trials
Fierce Biotech
Thu, 06/24/21 - 11:02 am
Roche
Genentech
clinical trials
clinical trial diversity
cancer
Advancing Inclusive Research Site Alliance
GSK outlines ambitious 10-year plan, but hits investors' near-term outlook
BioPharma Dive
Wed, 06/23/21 - 10:29 pm
GSK
investors
cancer
Immune
infectious disease
Include cancer patients in COVID-19 vaccine trials, say ASCO and Friends of Cancer Research
RAPS.org
Tue, 06/22/21 - 10:30 pm
cancer
ASCO
clinical trials
vaccines
COVID-19
patients
Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate
Reuters
Thu, 06/17/21 - 10:56 pm
Bristol Myers Squibb
Eisai
drug development
cancer
With Illumina Acquisition Pending, GRAIL Presents Multi-Cancer Detection Test
BioSpace
Mon, 06/7/21 - 08:32 pm
ASCO 2021
Grail
Illumina
M&A
diagnostics
clinical trials
cancer
Galleri
Roche, Pfizer and Novartis earn top marks from cancer patient groups during pandemic: survey
Fierce Pharma
Mon, 06/7/21 - 08:29 pm
cancer
patients
COVID-19
pandemic
Roche
Pfizer
Novartis
Bayer at ASCO: Vitrakvi Effective in TRK Fusion Cancers Regardless of Tumor Type
BioSpace
Sun, 06/6/21 - 10:31 pm
Bayer
ASCO 2021
Vitrakvi
cancer
This Biotech's Thrifty CEO Is Serious About Investing for the Future
Motley Fool
Thu, 06/3/21 - 10:34 am
BioNTech
vaccines
Pharma CEOs
cancer
Ugur Sahin
New JV from upstart biotechs Pyxis, Alloy aims for rapid drug development in cancer, autoimmune diseases
Fierce Biotech
Tue, 05/25/21 - 11:12 am
Pyxis Oncology
Alloy Therapeutics
Kyma Therapeutics
cancer
autoimmune disease
antibody-drug conjugate
What other conditions can mRNA take down? Several, according to pharmacists
Beckers Hospital Review
Sun, 05/23/21 - 02:50 pm
MRNA
vaccines
cancer
viruses
Flu
drug development
COVID-19
FDA Torpedoes CytoDyn's Leronlimab for COVID-19 with Rare Public Scolding
BioSpace
Tue, 05/18/21 - 11:08 pm
FDA
leronlimab
CytoDyn
HIV
cancer
monoclonal antibodies
Backed by $92M, startup Interline aims to shed new light on protein communities
MedCity News
Fri, 05/14/21 - 10:50 am
Interline Therapeutics
protein communities
drug discovery
funding
cancer
inflammatory diseases
OIG calls on EPA to review ethylene oxide cancer risks, possibly delaying new regulations until 2022
Medtech Dive
Tue, 05/11/21 - 11:54 am
EPA
OIG
devices
sterilization
cancer
ethylene oxide
Another 5 years of dominance: Oncology, immunology will extend their lead as pharma's top fields through 2025
Fierce Pharma
Fri, 05/7/21 - 10:39 am
biosimilars
oncology
immunology
autoimmune disease
cancer
Bluebird names oncology spinoff, establishes leadership team
Fierce Biotech
Thu, 05/6/21 - 10:58 am
Bluebird Bio
spinoffs
cancer
2seventy bio
Pandemic slowed sales of cancer, arthritis, diabetes drugs
Beckers Hospital Review
Mon, 05/3/21 - 10:48 am
COVID-19
pandemic
cancer
diabetes
arthritis
Merck
Keytruda
Amgen
Enbrel
At a Recent Cancer Research Conference, Instil Bio Stole the Show
Motley Fool
Thu, 04/29/21 - 10:30 am
Instil Bio
cancer
AACR
melanoma

Pages